APPLICATION OF YEAST CELL WALLS FOR TREATMENT AND / OR PREVENTION OF HYPERINSULINEMIA

摘要

1. The use of yeast cell walls to obtain a pharmaceutical composition intended for the treatment and / or prevention of hyperinsulinemia, where the yeast cell walls have! - the total content of glucans and mannans is at least 34.0% of the dry matter content by weight, and! - glycogen content of less than 10.0% of the dry matter content by weight. ! 2. The use according to claim 1, where the yeast cell walls belong to the yeast of the genus Saccharomyces cerevisiae. ! 3. The use according to claim 1, where the yeast cell walls have a total content of glucans and mannans of at least 40.0% of the dry matter content by weight. ! 4. The use according to claim 1, where the yeast cell walls have a total content of glucans and mannans of at least 45.0% of the dry matter content by weight. ! 5. The use according to claim 1, where the yeast cell walls have a mannan content of less than 30% dry matter by weight. ! 6. The use according to claim 1, where the yeast cell walls have a mannan content of less than 2% dry matter by weight. ! 7. The use according to claim 1, where the yeast cell walls have a mannan content of less than 1% dry matter content by weight. ! 8. The use according to claim 1, where the yeast cell walls have a total content of glucans and mannans equal to or less than 90% of the dry matter content by weight. ! 9. The use according to claim 1, where the yeast cell walls have a total content of glucans and mannans equal to or less than 80% of the dry matter content by weight. ! 10. The use according to claim 1, where the yeast cell walls, the total content of glucans and mannans from 45% to 90% of the dry matter content by weight. ! 11. Application by